Taken together, these results display discordant behavior of BRCA1/2m between patients with breast or ovarian cancer, suggesting possible tumor-intrinsic properties of ovarian cancers that combine with the presence of BRCA1/2m to lead to longer survival. This evidence concerns the gene BRCA1 and neoplasm.